Elektrofi
Ashita Nair is a Principal Scientist at Elektrofi since September 2021, previously serving as a Senior Scientist. Prior experience includes research roles at the University of Wisconsin-Madison from January 2017 to August 2021 and the University of Illinois at Chicago from August 2015 to December 2016, as well as a research assistant position at the National University of Singapore from July 2013 to June 2014. Nair's expertise encompasses in-vitro Molecular Biology methods, RNA Delivery, and drug screening for neurodegenerative diseases, alongside research focused on respiratory drug delivery during an internship at Pharmaterials Limited in 2012. Academic qualifications include a PhD in Pharmaceutical Sciences from the University of Wisconsin-Madison and a Master's degree in Drug Delivery from UCL School of Pharmacy, with a Bachelor's degree in Pharmacy from Hemchandracharya North Gujarat University.
This person is not in any teams
This person is not in any offices
Elektrofi
1 followers
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.